Showing results (3021-3030 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1983
In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitolN H Rubin, C Casartelli, B G Macik, et al.Investigational New Drugs|January 1, 1983
Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning systemJ D Cowan, D D Von Hoff, G M ClarkInvestigational New Drugs|January 1, 1983
Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D D Von Hoff, J A Neidhart, et al.Investigational New Drugs|January 1, 1983
Structure-activity relationship of 1-propargyl-5-halopyrimidin-2-ones. Metaphase arresting properties and competitive inhibition of colchicine binding to tubulinJ M Dornish, R OftebroInvestigational New Drugs|January 1, 1983
Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology GroupW A Knight, C Fabian, J J Costanzi, et al.Investigational New Drugs|January 1, 1983
The treatment of acute leukemia with continuous infusion L-AlanosineJ K Weick, B L Tranum, F S MorrisonInvestigational New Drugs|January 1, 1983
Pharmacokinetics of high dose melphalanM R Hersh, T M Ludden, J G Kuhn, et al.Investigational New Drugs|January 1, 1983
Colchicine in refractory chronic lymphocytic leukemia. A Southwest Oncology Group studyJ K Weick, R B Livingston, E J Van SlyckInvestigational New Drugs|January 1, 1995
Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 modelL H Ramirez, M Juliéron, M Bonnay, et al.Investigational New Drugs|January 1, 1995
Pharmacology, relative bioavailability, and toxicity of three different oral cyclophosphamide preparations in a randomized, cross-over studyD J Stewart, L R Morgan, S Verma, et al.Pageof 372